Cargando…
Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels
Kori-tofu is a frozen soy tofu, and soy consumption is associated with positive effects on cardiometabolic health markers. We aimed to assess the potential of Kori-tofu to improve cardiometabolic health outcomes in humans by repetitive daily consumption. In a double-blind randomized controlled cross...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824620/ https://www.ncbi.nlm.nih.gov/pubmed/36615709 http://dx.doi.org/10.3390/nu15010049 |
_version_ | 1784866454897688576 |
---|---|
author | van den Belt, Maartje van der Haar, Sandra Oosterink, Els van Loenhout, Tom Ishiguro, Takahiro Esser, Diederik |
author_facet | van den Belt, Maartje van der Haar, Sandra Oosterink, Els van Loenhout, Tom Ishiguro, Takahiro Esser, Diederik |
author_sort | van den Belt, Maartje |
collection | PubMed |
description | Kori-tofu is a frozen soy tofu, and soy consumption is associated with positive effects on cardiometabolic health markers. We aimed to assess the potential of Kori-tofu to improve cardiometabolic health outcomes in humans by repetitive daily consumption. In a double-blind randomized controlled cross-over trial, 45 subjects aged 40–70 years with (mildly) elevated cholesterol levels, received a four week Kori-tofu intervention or whey protein control intervention with a four week wash-out period in between. Cardiometabolic biomarkers were measured before and after both interventions. A significant decrease in total, low-density lipids (LDL), and high-density lipids (HDL) cholesterol, Hemoglobin A1c (HbA1c), fructosamine and systolic blood pressure was observed within the Kori-tofu intervention. However, many of these findings were also observed in the control intervention. Only adiponectin changes were different between treatments but did not change significantly within interventions. Improvements in cardiometabolic markers within the Kori-tofu intervention point toward potential beneficial health effects. Due to the lack of significant effects as compared to control, there is, however, currently no substantiating evidence to claim that Kori-tofu has beneficial effects on cardiometabolic health. |
format | Online Article Text |
id | pubmed-9824620 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98246202023-01-08 Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels van den Belt, Maartje van der Haar, Sandra Oosterink, Els van Loenhout, Tom Ishiguro, Takahiro Esser, Diederik Nutrients Article Kori-tofu is a frozen soy tofu, and soy consumption is associated with positive effects on cardiometabolic health markers. We aimed to assess the potential of Kori-tofu to improve cardiometabolic health outcomes in humans by repetitive daily consumption. In a double-blind randomized controlled cross-over trial, 45 subjects aged 40–70 years with (mildly) elevated cholesterol levels, received a four week Kori-tofu intervention or whey protein control intervention with a four week wash-out period in between. Cardiometabolic biomarkers were measured before and after both interventions. A significant decrease in total, low-density lipids (LDL), and high-density lipids (HDL) cholesterol, Hemoglobin A1c (HbA1c), fructosamine and systolic blood pressure was observed within the Kori-tofu intervention. However, many of these findings were also observed in the control intervention. Only adiponectin changes were different between treatments but did not change significantly within interventions. Improvements in cardiometabolic markers within the Kori-tofu intervention point toward potential beneficial health effects. Due to the lack of significant effects as compared to control, there is, however, currently no substantiating evidence to claim that Kori-tofu has beneficial effects on cardiometabolic health. MDPI 2022-12-22 /pmc/articles/PMC9824620/ /pubmed/36615709 http://dx.doi.org/10.3390/nu15010049 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article van den Belt, Maartje van der Haar, Sandra Oosterink, Els van Loenhout, Tom Ishiguro, Takahiro Esser, Diederik Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels |
title | Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels |
title_full | Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels |
title_fullStr | Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels |
title_full_unstemmed | Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels |
title_short | Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels |
title_sort | effect of 4-week consumption of soy kori-tofu on cardiometabolic health markers: a double-blind randomized controlled cross-over trial in adults with mildly elevated cholesterol levels |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824620/ https://www.ncbi.nlm.nih.gov/pubmed/36615709 http://dx.doi.org/10.3390/nu15010049 |
work_keys_str_mv | AT vandenbeltmaartje effectof4weekconsumptionofsoykoritofuoncardiometabolichealthmarkersadoubleblindrandomizedcontrolledcrossovertrialinadultswithmildlyelevatedcholesterollevels AT vanderhaarsandra effectof4weekconsumptionofsoykoritofuoncardiometabolichealthmarkersadoubleblindrandomizedcontrolledcrossovertrialinadultswithmildlyelevatedcholesterollevels AT oosterinkels effectof4weekconsumptionofsoykoritofuoncardiometabolichealthmarkersadoubleblindrandomizedcontrolledcrossovertrialinadultswithmildlyelevatedcholesterollevels AT vanloenhouttom effectof4weekconsumptionofsoykoritofuoncardiometabolichealthmarkersadoubleblindrandomizedcontrolledcrossovertrialinadultswithmildlyelevatedcholesterollevels AT ishigurotakahiro effectof4weekconsumptionofsoykoritofuoncardiometabolichealthmarkersadoubleblindrandomizedcontrolledcrossovertrialinadultswithmildlyelevatedcholesterollevels AT esserdiederik effectof4weekconsumptionofsoykoritofuoncardiometabolichealthmarkersadoubleblindrandomizedcontrolledcrossovertrialinadultswithmildlyelevatedcholesterollevels |